Esketamine for treatment resistant depression
On 5 March 2019 the US Food and Drug Administration approved esketamine nasal spray in conjunction with an oral antidepressant for people with treatment resistant depression. Esketamine is a form of…
Read Original Article: Esketamine for treatment resistant depression »
